Qiagen (QGEN) Cash from Investing Activities (2010 - 2026)
Qiagen's (QGEN) quarterly Cash from Investing Activities came in at $211.5 million in Q1 2026, up 76.11% year-on-year from $120.1 million in Q1 2025, and up 169.34% quarter-over-quarter from -$305.0 million in Q4 2025.
Qiagen (QGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Qiagen has disclosed Cash from Investing Activities across 16 years of filings, most recently posting $211.5 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $211.5 million, up 76.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$292.4 million (up 22.63% YoY), and the FY2025 annual result was -$305.3 million, down 22.49% from the prior year.
- Cash from Investing Activities came in at $211.5 million for Q1 2026 at Qiagen, up from -$305.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $248.4 million in Q3 2023 to a low of -$727.0 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$88.0 million (2023), against an average of -$124.1 million.
- Across the five-year window, Cash from Investing Activities slumped 388.99% in 2022 and surged 1776.27% in 2025, its largest moves.
- Qiagen's Cash from Investing Activities stood at -$727.0 million in 2022, then surged by 87.9% to -$88.0 million in 2023, then sank by 182.95% to -$249.0 million in 2024, then fell by 22.49% to -$305.0 million in 2025, then surged by 169.34% to $211.5 million in 2026.
- The last three Cash from Investing Activities figures came in at $211.5 million (Q1 2026), -$305.0 million (Q4 2025), and -$156.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Qiagen | 8.54 Bn | 7.44 Bn | - | 211.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.47 Mn |
| Mar 31, 2026 | 211.47 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Sep 30, 2025 | -156.91 Mn |
| Sep 30, 2025 | -156.91 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Mar 31, 2025 | 120.08 Mn |
| Mar 31, 2025 | 120.08 Mn |
| Dec 31, 2024 | -249.00 Mn |
| Dec 31, 2024 | -249.00 Mn |
| Sep 30, 2024 | -231.04 Mn |
| Sep 30, 2024 | -231.04 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Dec 31, 2023 | -88.00 Mn |
| Dec 31, 2023 | -88.00 Mn |